Welcome to LookChem.com Sign In|Join Free

CAS

  • or
carbonic acid ethyl ester 4-(2-hydroxy-ethyl)-phenyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1119076-06-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • carbonic acid ethyl ester 4-(2-hydroxy-ethyl)-phenyl ester

    Cas No: 1119076-06-0

  • Need to discuss

  • No requirement

  • Adequate

  • YANGQINGRONG
  • Contact Supplier
  • 1119076-06-0 Structure
  • Basic information

    1. Product Name: carbonic acid ethyl ester 4-(2-hydroxy-ethyl)-phenyl ester
    2. Synonyms: carbonic acid ethyl ester 4-(2-hydroxy-ethyl)-phenyl ester
    3. CAS NO:1119076-06-0
    4. Molecular Formula:
    5. Molecular Weight: 210.23
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1119076-06-0.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: carbonic acid ethyl ester 4-(2-hydroxy-ethyl)-phenyl ester(CAS DataBase Reference)
    10. NIST Chemistry Reference: carbonic acid ethyl ester 4-(2-hydroxy-ethyl)-phenyl ester(1119076-06-0)
    11. EPA Substance Registry System: carbonic acid ethyl ester 4-(2-hydroxy-ethyl)-phenyl ester(1119076-06-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1119076-06-0(Hazardous Substances Data)

1119076-06-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1119076-06-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,1,9,0,7 and 6 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1119076-06:
(9*1)+(8*1)+(7*1)+(6*9)+(5*0)+(4*7)+(3*6)+(2*0)+(1*6)=130
130 % 10 = 0
So 1119076-06-0 is a valid CAS Registry Number.

1119076-06-0Relevant articles and documents

Design, synthesis, nitric oxide release and antibacterial evaluation of novel nitrated ocotillol-type derivatives

Bi, Yi,Yang, Xiao,Zhang, Tingting,Liu, Zeyun,Zhang, Xiaochen,Lu, Jing,Cheng, Keguang,Xu, Jinyi,Wang, Hongbo,Lv, Guangyao,Lewis, Peter John,Meng, Qingguo,Ma, Cong

, p. 71 - 80 (2015)

Abstract Nitric oxide (NO) and its auto-oxidation products are known to disrupt normal bacterial function and NO releasing molecules have the potential to be developed as antibacterial leads in drug discovery. We have designed and synthesized a series of

Discovery and synthesis of 3- and 21-substituted fusidic acid derivatives as reversal agents of P-glycoprotein-mediated multidrug resistance

Guo, Mengqi,Ren, Qianwen,Wang, Binghua,Ji, Wentao,Ni, Jingxuan,Feng, Yaqi,Bi, Yi,Tian, Jingwei,Wang, Hongbo

, (2019)

In this study, we synthesized 23 fusidic acid (FA) derivatives and screened them for tumor drug resistance reversal activity and cytotoxicity toward the KBV (multidrug-resistant oral epidermoid carcinoma) cell line based on MTT assay. Tumor resistance reversal activity of fusidic acid (FA) derivatives was discovered for the first time. Our results showed that compound 1 enhanced the cytotoxicity of paclitaxel toward the drug-resistant KBV cells at a concentration of 5 μM. And compound 1 sensitized KBV cells toward paclitaxel in arresting cells in the G2/M phase and inducing cell apoptosis. Further researches showed that compound 1 inhibited the drug efflux activity of P-glycoprotein (P-gp) by increasing the ATPase activity of P-gp without affecting its expression. The structure-activity relationships (SARs) of the FA derivatives were also preliminarily investigated. Our findings indicate that compound 1 is a promising lead compound for designing FA derivatives with improved tumor drug resistance reversal activity in the future.

Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity

Liu, Xian-xuan,Yang, Yan-ting,Wang, Xiao,Wang, Kai-yi,Liu, Jia-qi,Lei, Lei,Luo, Xiao-min,Zhai, Rong,Fu, Feng-hua,Wang, Hong-bo,Bi, Yi

, p. 427 - 439 (2017/10/17)

In an attempt to arrive at a more potent cytotoxic agent than the parent compound α-hederagenin (H), 24 α-hederagenin derivatives (5–8, 11–24, 27–28, 31–32, and 35–36) were synthesized in a concise and efficient strategy and screened for in vitro cytotoxicity against the human cancer cell lines MKN45 and KB. Among these compounds, the polyamine derivative 15 exhibited more potency than the parent compound with IC50 values in the range of 4.22 μM–8.05 μM. Compound 15 increased Bax/bcl-2 ratio that disrupted the mitochondrial potential and induced apoptosis. Therefore, the present studies highlight the importance of polyamine derivatives of α-hederagenin in the discovery and development of novel anticancer agents.

Iodination of verapamil for a stronger induction of death, through GSH efflux, of cancer cells overexpressing MRP1

Barattin, Régis,Perrotton, Thomas,Trompier, Doriane,Lorendeau, Doriane,Pietro, Attilio Di,D'Hardemare, Amaury Du Moulinet,Baubichon-Cortay, Hélne

experimental part, p. 6265 - 6274 (2010/10/19)

The multidrug resistance protein 1 (MRP1), involved in multidrug resistance (MDR) of cancer cells, was found to be modulated by verapamil, through stimulation of GSH transport, leading to apoptosis of MRP1-overexpressing cells. In this study, various iodi

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1119076-06-0